Blue Jet Healthcare Limited (NSE:BLUEJET)
India · Delayed Price · Currency is INR 796.30
-9.65 (-1.20%)
Aug 1, 2025, 3:30 PM IST
Chimerix Revenue
Blue Jet Healthcare had revenue of 3.55B INR in the quarter ending June 30, 2025, with 117.78% growth. This brings the company's revenue in the last twelve months to 12.22B, up 75.82% year-over-year. In the fiscal year ending March 31, 2025, Blue Jet Healthcare had annual revenue of 10.30B with 44.74% growth.
Revenue (ttm)
12.22B
Revenue Growth
+75.82%
P/S Ratio
11.31
Revenue / Employee
27.33M
Employees
447
Market Cap
138.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.30B | 3.18B | 44.74% |
| Mar 31, 2024 | 7.12B | -93.84M | -1.30% |
| Mar 31, 2023 | 7.21B | 375.13M | 5.49% |
| Mar 31, 2022 | 6.83B | 1.85B | 36.99% |
| Mar 31, 2021 | 4.99B | -392.63M | -7.30% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 274.80B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Fortis Healthcare | 77.86B |